Nuvectis Pharma, Inc. ( NVCT) - Stock Earnings
NVCT Quarterly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2025Q4 | -7.3 million USD | — USD |
| 2026Q1 | -6.1 million USD | — USD |
| 2026Q2 | -7.0 million USD | — USD |
| 2026Q3 Est. | — | — |
| 2026Q4 Est. | — | — |
NVCT Yearly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -22.3 million USD | — USD |
| 2024 | -19.0 million USD | — USD |
| 2025 | -26.4 million USD | — USD |
| 2026 Est. | — | — |
NVCT
Price: $23.35
52 week price:
Earnings Per Share: -1.32 USD
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Market Capitalization: 617.4 million